Halozyme Therapeutics, Inc. (HALO)
125.63
+1.09
(+0.88%)
USD |
NASDAQ |
Oct 23, 16:00
125.59
-0.04
(-0.03%)
After-Hours: 20:00
Halozyme Therapeutics Market Cap : 14.33B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 14.33B |
| October 22, 2026 | 14.20B |
| October 21, 2026 | 14.24B |
| October 20, 2026 | 14.18B |
| October 19, 2026 | 13.97B |
| October 16, 2026 | 13.89B |
| October 15, 2026 | 13.86B |
| October 14, 2026 | 13.32B |
| October 13, 2026 | 12.50B |
| October 12, 2026 | 12.67B |
| October 09, 2026 | 12.59B |
| October 08, 2026 | 12.53B |
| October 07, 2026 | 12.63B |
| October 06, 2026 | 12.51B |
| October 05, 2026 | 12.35B |
| October 02, 2026 | 12.53B |
| October 01, 2026 | 12.20B |
| September 30, 2026 | 12.59B |
| September 29, 2026 | 12.72B |
| September 28, 2026 | 12.87B |
| September 25, 2026 | 12.99B |
| September 24, 2026 | 13.14B |
| September 23, 2026 | 12.82B |
| September 22, 2026 | 13.13B |
| September 21, 2026 | 12.71B |
| Date | Value |
|---|---|
| September 18, 2026 | 12.82B |
| September 17, 2026 | 12.51B |
| September 16, 2026 | 12.37B |
| September 15, 2026 | 12.12B |
| September 14, 2026 | 12.31B |
| September 11, 2026 | 12.23B |
| September 10, 2026 | 12.20B |
| September 09, 2026 | 12.25B |
| September 08, 2026 | 12.35B |
| September 04, 2026 | 12.57B |
| September 03, 2026 | 12.63B |
| September 02, 2026 | 12.51B |
| September 01, 2026 | 12.28B |
| August 31, 2026 | 12.14B |
| August 28, 2026 | 12.01B |
| August 27, 2026 | 12.19B |
| August 26, 2026 | 12.21B |
| August 25, 2026 | 12.47B |
| August 24, 2026 | 12.39B |
| August 21, 2026 | 12.34B |
| August 20, 2026 | 12.10B |
| August 19, 2026 | 12.27B |
| August 18, 2026 | 11.96B |
| August 17, 2026 | 11.75B |
| August 14, 2026 | 11.25B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AVITA Medical, Inc. | 479.67M |
| Iovance Biotherapeutics, Inc. | 6.382B |
| Merck & Co., Inc. | 358.62B |
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
Market Cap Related Metrics
| PE Ratio | 37.54 |
| PS Ratio | 9.138 |
| Price to Book Value | 99.81 |
| Price to Free Cash Flow | 18.86 |
| Price | 125.63 |
| Earnings Yield | 2.66% |
| Operating PE Ratio | 16.10 |
| Normalized PE Ratio | 23.07 |